CrushSCI.com
90.2平均天数
79中位天数
6最短天数
258最长天数
422025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

108 天

A simple and convenient method for the purification of Haemophilus Influenzae type b polysaccharide PRP

作者
Darshan Gandhi; Rahul Patil; Manoj Joshi; Sunil Goel; Rajeev Dhere; Cyrus Poonawalla; Suresh Beri展开收起
作者单位
Serum Institute of India Pvt. Ltd., Pune, India展开收起
PDF源文件 DOI 网页
9 天

From discovery to innovation in animal health: meeting report of the second DIAH conference

作者
Johannes Charlier; Laetitia Cicchelero; Beatrice Vos; Juerg Baggenstoss; Hervé Poulet; Dieter Vancraeynest; Sven Arnouts展开收起
作者单位
Kreavet BV, Hendrik Mertensstraat 17, Kruibeke, 9150, Belgium; Ghent University, Salisburylaan 133, Merelbeke, 9820, Belgium; Stonehaven Cozmix Group, Schlossmühlestrasse 9, Frauenfeld, 8500, Switzerland; Boehringer-Ingelheim, 29 Avenue Tony Garnier, Lyon, 69007, France; Zoetis, Mercuriusstraat 20, Zaventem, 1930, Belgium展开收起
PDF源文件 DOI 网页
11 天

Assessing consequences of maternal immunization on fetal outcomes - A meeting report

作者
Stephen Evans; Flor M. Munoz; Steve Black; Kathryn M. Edwards; Nick J. Andrews; Benjamin Atkins; Madhava Ram Balakrishnan; Marco Cavaleri; Hannah G. Davies; Alemayehu Duga; Janet A. Englund; Deshayne B. Fell; Delyth Jones; Kirsty Le Doare; Gwen Lemey; Shabir Madhi; Souad Mansouri; Solange Milolo Tshilumba; Jezid Miranda; Paulina Morales-Ruiz; Victoria Prudence Nambasa; Hanna Nohynek; Julien Nyombayire; Lidia Oostvogels; David Radley; Annette Regan; Anna C. Seale; Katerina Rok Song; James Southern; Jens-Ulrich Stegmann; Marc Baay; Pieter Neels; Frank Vandendriessche展开收起
作者单位
International Alliance of Biological Standardisation, Geneva, Switzerland; Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Global Vaccine Data Network Uniservices, Auckland, 1010, New Zealand; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK; Department Epidemiology Informatics, Murdoch Children's Research Institute, Parkville, Victoria, 3052, Australia; Pharmacovigilance Unit, World Health Organization, Geneva, Switzerland; EMA, Amsterdam, Netherlands; Centre for Neonatal and Paediatric Infection, City St George's, University of London, London, UK; London School of Hygiene & Tropical Medicine, London, UK; Department for Infection and Population Health, Institute for Global Health, University College London, UK; Africa Centres for Disease Control and Prevention (Africa CDC), Addis Ababa, Ethiopia; Seattle Children's Research Institute and Department of Pediatrics, University of Washington, 4800 Sand Point Way NE, Seattle, WA, 98105, USA; Medical Evidence Development, Pfizer Inc., New York, USA; GSK, Stevenage, UK; Makerere University Johns Hopkins Research Collaboration (MUJHU), Kampala, Uganda; Global Health Institute (GHI), University of Antwerp, Antwerp, Belgium; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; BioNet, 19 Soi Udomsuk 37, Sukhumvit 103 Road, Bangjak, Prakanong, Bangkok, 10260, Thailand; Clinical Research and Immunization, Department of Tropical Medicine, University of Kinshasa, Kinshasa, Democratic Republic of the Congo; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Cartagena, Zaragocilla Carrera 50 #24-63, Cartagena de Indias, 130014, Colombia; African Union Development Agency-NEPAD, Johannesburg, South Africa; Finnish Institute for Health and Welfare, Helsinki, Finland; Center for Family Health Research, P.O. Box 780, Kigali, Rwanda; MinervaX ApS, Frederiksberg, Denmark; Pfizer Vaccines, Pfizer Inc., Pearl River, NY, USA; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 91101, USA; School of Nursing and Health Professions, University of San Francisco, Orange, CA, 92686, USA; Global Health Division, Gates Foundation, Seattle, USA; International Vaccine Institute, Seoul, Republic of Korea; South African Health Products Regulatory Authority (SAPHRA), Gauteng, South Africa; GSK, Wavre, Belgium; P95 Clinical & Epidemiology Services, Leuven, Belgium展开收起
PDF源文件 DOI 网页
13 天

Globally harmonized specifications: Implementing a patient-centric, enhanced control strategy – a meeting report

作者
Yoji Sato; Andrew Chang; Cristiana Campa; Robin Levis; Masayo Takahashi; Phil Krause; Akiko Ishii-Watabe; Takahiro Yamaguchi; Horacio Pappa; Keiko Funato; Bénédicte Mouterde; Patrice Riou; Gerald Gellermann; Marisa K. Joubert; Vanessa Auquier; Jayda Siggers; Emmanuelle Charton; Anuradha Gupta; Minkyung Kim; Hiroko Shibata; Sirichair Krabesri; Sasiwimon Patasema; Jayoung Kim; Daisy Nie; Kaushik Sarkar; Shin Kawamata; Kok-Yew Ngew; Dean Smith; Shawn Novick展开收起
作者单位
National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki Ward, Kawasaki, Kanagawa, 210-9501, Japan; Novo Nordisk, 800 Scudders Mill Road Plainsboro, NJ, 08536, USA; GSK, Viale Dell'Agricoltura, 7, Verona, VR, 37135, Italy; Center for Biologics Evaluation and Research of the US Food and Drug Administration, 1401 Rockville Pike, Suite 200N/HFM-47, Rockville, MD, 20852-1448, USA; Riken Center for Developmental Biology, 2-2-3 Minatojima-minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan; Asahi Kasei Pharma Corporation, 632-1, Izunokuni, Shizuoka, 410-2321, Japan; United States Pharmacopeia, 12601 Twinbrook Pkwy, Rockville, MD, 20852-1717, USA; GlaxoSmithKline, Akasaka Intercity AIR, 1-8-1 Akasaka, Minato-ku, Tokyo, 107-0052, Japan; Sanofi, 1541, Avenue Marcel Merieux, Marcy L’Etoile, 69280, France; Novartis Pharma Services AG, Lichtstrasse 35, Basel, CH-4056, Switzerland; Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA; Union Chimique Belge, Allée de La Recherche, Brussels, 60 1070, Belgium; Health Canada, 1801B, Ottawa, Ontario, K1A 0K9, Canada; European Directorate for the Quality of Medicines & HealthCare, 7 Allée Kastner, CS 30026, Strasbourg, F-67081, France; Indian Pharmacopoeia Commission, Sector 23, Raj Nagar Ghaziabad, Uttar Pradesh, 201002, India; Thai Pharmacopeia, Institute of Thai Traditional Medicine, Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Nonthaburi, 11000, Thailand; Korean Pharmacopeia, 187, Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea; Novartis Pharmaceuticals Corporation, 1 Health Plz, East Hanover, NJ, 07936, USA; Novo Nordisk A/S, Novo Allé, Bagsvaerd, 2880, Denmark; Cyto-Facto, Shimin Byoin Mae Bldg 3F, 2-1-11 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan; P95 Epidemiology and Pharmacovigilance, Koning Leopold III Laan 1, Leuven, 3001, Belgium; IABS, Rue de L’Est 8, Geneva, CH-1207, Switzerland展开收起
PDF源文件 DOI 网页
258 天

Development and validation of a quantitative real-time PCR method for determination of residual host DNA in recombinant human C1 esterase inhibitor (rhC1INH)

作者
Cong Cong; Xiaoping Yu; Tianfei Du; Yali Gao; Jiayao Tian; Chunyang Li; Lanjun Liu展开收起
作者单位
Chengdu Institute of Biological Products Co.,Ltd, Chengdu, Sichuan Province, 610023, China展开收起
PDF源文件 DOI 网页
94 天

Supporting 3Rs approaches in biologicals testing: responses from a survey of Manufacturers, Contract Research Organisations, National Control Laboratories and National Regulatory Authorities

作者
Elliot Lilley; Sunil Goel; Robin Levis; Shajahan Shaid; Sarah Sheridan; Paul Stickings; Laura Viviani; Anthony Holmes展开收起
作者单位
NC3Rs, London, United Kingdom; Serum Institute of India, India; Food and Drug Administration, USA; GlaxoSmithKline, Germany; Merck, Glasgow, United Kingdom; Medicines and Healthcare Products Regulatory Agency, United Kingdom; SciEthiq, Italy展开收起
PDF源文件 DOI 网页

FAQ

BIOLOGICALS审稿要多久?

截至2026-11-19,CrushSCI 收录了 BIOLOGICALS 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 6 天(Report of the international conference on animal testing replacement for vaccines: A one health view on global outlook and future strategy,2026-07-15 收稿,2026-07-21 录用),最慢一篇用了 258 天;平均 90.2 天,中位数 79 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。